President Donald Trump has signed an executive order aimed at reforming the childhood vaccine schedule in the United States, citing alignment with peer countries and parental choice, as measles cases increase nationwide. The move revives debates over vaccine safety and policy flexibility, with experts warning against undermining established immunisation practices.
President Donald Trump has signed an executive order that would push the federal government towards a slimmer childhood vaccine schedule, while urging states to rethink school vaccination requirements. The move, which the White House says is intended to align the United States with peer countries, directs federal agencies to review and revise guidance on the timing and sequencing of routine immunisations.
The order revives one of Trump’s longest-running public positions on vaccines: his preference for separating the measles, mumps and rubella shot into individual injections. Medical experts have repeatedly rejected claims that the combined MMR vaccine is linked to autism, and public health specialists say there is no evidence that splitting the doses offers any medical benefit. The White House said the policy is meant to preserve parental choice and religious freedom while reducing the number of recommended childhood vaccines.
According to the administration, the directive follows a scientific assessment from the Department of Health and Human Services that compared US recommendations with those of other wealthy countries. That review found that the United States recommends more childhood vaccines than any peer nation, and the order instructs the Centres for Disease Control and Prevention and its vaccine advisory committee to examine the findings and update the schedule as appropriate. The White House also said the aim is to give parents and doctors greater flexibility over when and how routine shots are given.
The policy change is likely to be more limited than Trump’s language suggests. School entry requirements are set by the states, not Washington, and any change to the federal childhood immunisation schedule would still have to move through the CDC’s normal advisory process. Private insurers are also still required to cover all vaccines recommended by the CDC’s advisory panel at no cost, including those placed in shared decision-making categories, although some broader coverage promises from insurers are due to run through at least 2026.
The debate is unfolding as the US faces a surge in measles cases. CDC data cited in the reporting shows 2,465 cases across 47 states so far in 2026, already above last year’s total, with unvaccinated people accounting for most infections. The agency also says the MMR vaccine remains highly effective and that serious side effects are rare, while major medical groups continue to back the established schedule as the safest way to protect children early in life.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
